Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 71 - 80 of 412

Press

Correction Statement

2020.01.24 Read more

Press

Recipharm further extends the acceptance period for the offer to acquire Consort Medical and updates on level of acceptance

2020.01.24 Read more

Press

Recipharm acquires shares in Consort Medical

2020.01.22 Read more

Press

Recipharm receives competition clearance from German competition authorities for the offer to acquire Consort Medical

2020.01.14 Read more

Press

Recipharm extends the acceptance period for the offer to acquire Consort Medical and updates on level of acceptance

2020.01.10 Read more

Press

Recipharm partners with Aptahem for formulation of Apta-1 drug candidate

2019.12.17 Read more

Press

Recipharm invests in its US inhalation development service

2019.12.09 Read more

Press

Recipharm publishes Offer Document regarding offer to acquire Consort Medical

2019.12.06 Read more

Press

Recipharm announces commercial manufacturing to support Talicia[®] Q1/2020 Launch following U.S. FDA approval

2019.11.27 Read more

Press

Larger institutional shareholders support Recipharm’s cash offer for Consort Medical and subsequent rights issue

2019.11.26 Read more